| Literature DB >> 31662624 |
S S El-Hawary1, K F Taha2, F N Kirillos1, A A Dahab3, A A El-Mahis2, S H El-Sayed4,5.
Abstract
Schistosomiasis remains to be the most common fibrotic disease resulting from inflammation and deposition of scar tissue around trapped parasitic eggs in the liver. Though chemotherapy eradicates matured worms efficiently and prevents the accumulation of schistosome eggs, fewer effective drugs are directed to reverse the present hepatic fibrosis. Therefore, treatment targeting hepatic fibrosis associated with schistosomiasis remains a challenging proposition. The present study was designed to investigate the potential complementary schistosomicidal and hepatoprotective activities of the methanol extract of Capparis spinosa L. (C. spinosa) with or without praziquantel (PZQ) and compare results with silymarin (Milk thistle), a known hepatoprotective and antifibrotic agent, on induced liver fibrosis by experimental Schistosoma mansoni (S. mansoni) infection. Total polyphenols in the extract were determined using colorimetric assay. C. spinosa L. caused a partial decrease in worm burden; a statistically significant reduction in hepatic and intestinal tissue egg load, what was associated histopathologically with decreasing in both the number and diameter of granulomas, as well as restoring serum aminotransferases (AST & ALT), alkaline phosphatase (ALP) and improving liver albumin synthesis. The best results were obtained in the group of mice treated with C. spinosa L. and PZQ together. Quantitative estimation of total polyphenols content using colorimetric assay showed that C. spinosa L. leaves contain higher concentration of polyphenolic compounds than fruits. It was concluded that C. spinosa L. has a promising hepatoprotective and antifibrotic properties and could be introduced as a safe and effective therapeutic tool with PZQ in the treatment of schistosomal liver fibrosis. Nevertheless further studies on the mechanism of action of C. spinosa L. in chronic liver diseases may shed light on developing therapeutic methods in clinical practice.Entities:
Keywords: Capparis spinosa L.; Schistosoma mansoni; colorimetric assay; hepatoprotective; praziquantel; silymarin
Year: 2018 PMID: 31662624 PMCID: PMC6799534 DOI: 10.1515/helm-2017-0055
Source DB: PubMed Journal: Helminthologia ISSN: 0440-6605 Impact factor: 1.184
The absorbance of different concentrations of standard gallic acid.
| Concentration (μg/ml) | Absorbance (760 nm) |
|---|---|
| 5 | 0.037 |
| 10 | 0.069 |
| 20 | 0.146 |
| 30 | 0.24 |
| 40 | 0.3 |
| 50 | 0.39 |
| 60 | 0.45 |
| 70 | 0.533 |
| 80 | 0.58 |
| 90 | 0.701 |
Effect of C. spinosa L. and silymarine with/without praziquantel treatment on worm burden in mice infected with S.mansoni.
| WORM BURDEN | |||||
|---|---|---|---|---|---|
| Groups | Male worm | Female worm | Couple worm | Total worms | Reduction % |
| Infected (vehicle) | 4.8 ± 0.56 | 2.60 ± 0.07 | 7 ± 0.58 | 21.40 ± 0.91 | - |
| Inf + PZQ | 0.67 ± 0.28* | 0* | 0.67 ± 0.28* | 2 ± 0.28* | 91 |
| Inf + CAP | 2.75 ± 0.5 | 1.75 ± 0.96 | 7 ± 0.82 | 18.5 ± 0.62 | 14 |
| Inf+ PZQ + CAP | 0.5 ± 0.12* | 0* | 0.25 ± 0.10* | 0.75 ± 0.29* | 96 |
| Inf + SIL | 3.50 ± 0.17 | 2 ± 0.41 | 6.50 ± 0.71 | 18 ± 0.84 | 16 |
| Inf+ PZQ + SIL | 0.67 ± 0.28* | 0* | 0.33 ± 0.20* | 1.33 ± 0.12* | 94 |
Data are presented as mean ± SEM (standard error of the mean) (n = 10 in each group).
*Significantly different from infected (vehicle) group at P < 0.001.
Effect of C. spinosa L. and silymarine with/without praziquantel treatment on oogram pattern in mice infected with S.mansoni.
| Oogram pattern (%) | |||
|---|---|---|---|
| Groups | Immature ova | Mature ova | Dead ova |
| Infected (vehicle) | 48.60 ± 3.51 | 45.20 ± 3.27 | 6.20 ± 1.10 |
| Inf + PZQ | 2.67 ± 0.12* | 2.33 ± 0.80* | 95 ± 1.30* |
| Inf + CAP | 39.25 ± 2.99 | 46.75 ± 2.99 | 14 ± 1.63 |
| Inf+ PZQ+ CAP | 0.75 ± 0.50* | 1 ± 0.82* | 98.25 ± 1.26* |
| Inf + SIL | 50.5 ± 2.12 | 40 ± 2.54 | 9.5 ± 2.12 |
| Inf+ PZQ + SIL | 1 ± 0.33* | 0.67 ± 0.18* | 98.33 ± 1.53* |
Data are presented as mean ± SEM (n = 10 in each group)
* Significantly different from infected (vehicle) group at P < 0.001
Effect of C. spinosa L. and silymarine with/without praziquantel treatment on tissue egg load in mice infected with S.mansoni.
| Tissue egg load/gm × 103 | ||||
|---|---|---|---|---|
| Groups | Hepatic tissue | Intestinal tissue | ||
| Egg load | Reduction % | Egg load | Reduction % | |
| Infected (vehicle) | 29.69 ± 0.31 | - | 31.61 ± 0.72 | - |
| Inf + PZQ | 5.79 ± 0.83* | 80 | 0.98 ± 0.36* | 97 |
| Inf + CAP | 16.26 ± 0.86* | 45 | 12.17 ± 0.95* | 62 |
| Inf + PZQ + CAP | 1.06 ± 0.36* | 96 | 0* | 100 |
| Inf + SIL | 19.62 ± 0.53* | 34 | 8.63 ± 0.30* | 30 |
| Inf + PZQ + SIL | 0.50 ± 0.38 * | 98 | 0* | 100 |
Data are presented as mean ± SEM (n = 10 in each group).
* Significantly different from infected (vehicle) group at P < 0.001.
Effect of C. spinosa L. and silymarine with/without praziquantel treatment on liver function tests 8 weeks post S.mansoni mice infection.
| Animal Groups | Serum AST (U/L) | Serum ALT (U/L) | Serum Albumin (gm/dl) | Serum ALP (U/L) |
|---|---|---|---|---|
| Uninfected (vehicle) | 42.67 ± 0.52 | 26.33 ± 1.53 | 3.47 ± 0.15 | 32.33 ± 1.15 |
| Infected (vehicle) | 111.8 ± 2.86 * | 53.8 ± 0.38 * | 1.9 ± 0.27 * | 87 ± 1.41 * |
| Inf + PZQ | 70.83 ± 0.64 ** | 39.4 ± 1.09 ** | 2.94 ± 0.11 ** | 59 ± 1.43 ** |
| Inf + CAP | 81.5 ± 1.11 ** | 45.5 ± 1.29 ** | 3.03 ± 0.51 ** | 65.75 ± 1.06 ** |
| Inf + PZQ + CAP | 62.25 ± 1.59 ** | 30.75 ± 0.84** | 3.36 ± 0.04 ** | 48.75 ± 1.71 ** |
| Inf + SIL | 89.5 ± 0.71 ** | 49.75 ± 0.35 ** | 2.75 ± 0.07 ** | 73 ± 1.14 ** |
| Inf + PZQ + SIL | 67.17 ± 0.76 ** | 35.5 ± 0.5 ** | 3.1 ± 0.5 ** | 54.67 ± 1.08 ** |
Data are presented as mean ± SEM (n = 10 in each group).
ALT, Alanine aminotransferase; AST, Aspartate transaminase; ALP, Alkaline phosphatase.
*Significantly different from uninfected (vehicle) group at P < 0.05. ** Significantly different from infected (vehicle) group at P < 0.05.
Fig. 1Histopathological examination of haematoxylin and eosin stained liver sections (a) Infected control group demonstrating large fibrocellular granuloma surrounding one intact egg (arrow) and peripheral zone of inflammatory cells, (b) Infected mice treated with PZQ demonstrating granuloma with loose fibrotic reaction (arrow) and dead egg (arrow head), (c) Infected mice treated with C. spinosa L. extract demonstrating notable reduction in granuloma size, with loosening of the central fibrous area of granulomatous reaction (arrow) and dense inflammatory cellular response (arrow head), (d) Infected mice treated with C.spinosa L. extract and PZQ demonstrating moderate loose of fibrotic reaction (arrow), dead egg (arrow head) and less cellular inflammatory infiltrate around (short arrow), (e) Infected mice treated with silymarin demonstrating compact granuloma with dense fibrotic reaction (arrow), intact egg (arrow head) and inflammatory area (double arrow), (f) Infected mice treated with silymarin and PZQ focusing on granuloma with dead egg (arrow), loose inflammatory infiltration (double arrow), hepatocyte with vacuolated cytoplasm (arrow head) (x: 400).
Fig. 2Histopathological examination of liver sections from (a) Infected control group demonstrating granuloma with compact fibrous reaction (arrow) intact egg (arrow head) and moderate inflammation, (b) Infected mice treated with PZQ demonstrating loose fibrous area and mild degree of inflammatory reaction (arrow), (c) Infected mice treated with C. spinosa L. extract demonstrating granuloma with loose fibrosis, dead egg (arrow) and external layer of inflammatory cells (arrow head), (d) Infected mice treated with C.spinosa L. extract and PZQ demonstrating granuloma with loose fibrotic reaction and dead egg (arrow), (e) Infected mice treated with silymarin demonstrating granuloma with intact egg (arrow head) and compact surrounding granuloma, (f) Infected mice treated with silymarin and PZQ demonstrating loose of fibrous area around dead egg and less inflammatory reaction (arrow) [Masson’s Trichrome x: 400].
Effect of C. spinosa. L. and silymarine with/without praziquantel treatment on hepatic granuloma number and diameter 8 weeks post S.mansoni mice infection.
| Groups | Mean number of granuloma in 10 successive power fields | Mean granuloma diameter in μm |
|---|---|---|
| Infected (vehicle) | 11.63 ± 1.52 | 347.34+17.24 |
| Inf + PZQ | 5.26 ± 1.26* | 231.56 ± 23.34* |
| Inf + CAP | 7.33 ± 2.12* | 239.34 ± 14.45* |
| Inf + PZQ + CAP | 4.29 ± 1.34* | 212.74 ± 24.54* |
| Inf + SIL | 6.14 ± 1.14* | 234 ± 16.62* |
| Inf + PZQ + SIL | 3.25 ± 0.12* | 207 ± 13.34* |
Data are presented as mean ± SEM (n = 10 in each group).
* Significantly different from uninfected (vehicle) group at P < 0.05.